1
Boersma, Cornelis, Broere, Adriaan, Postma, Maarten J.
Veröffentlicht in: Boersma , C , Broere , A & Postma , M J 2010 , ' Quantification of the Potential Impact of Cost-effectiveness Thresholds on Dutch Drug Expenditures Using Retrospective Analysis ' , Value in Health , vol. 13 , no. 6 , pp. 853-856 . https://doi.org/10.1111/j.1524-4733.2010.00736.x;
2010
Veröffentlicht in: Boersma , C , Broere , A & Postma , M J 2010 , ' Quantification of the Potential Impact of Cost-effectiveness Thresholds on Dutch Drug Expenditures Using Retrospective Analysis ' , Value in Health , vol. 13 , no. 6 , pp. 853-856 . https://doi.org/10.1111/j.1524-4733.2010.00736.x;
2010
2
Quist, Sara W., van Schoonhoven, Alexander V., Bakker, Stephan J.L., Pochopień, Michał, Postma, Maarten J., van Loon, Jeanni M.T., Paulissen, Jeroen H.J.
Veröffentlicht in: Quist , S W , van Schoonhoven , A V , Bakker , S J L , Pochopień , M , Postma , M J , van Loon , J M T & Paulissen , J H J 2023 , ' Cost-effectiveness of finerenone in chronic kidney disease associated with type 2 diabetes in The Netherlands ' , Cardiovascular Diabetology , vol. 22 , no. 1 , 328 . https://doi.org/10.1186/s12933-023-02053-6;
2023
Veröffentlicht in: Quist , S W , van Schoonhoven , A V , Bakker , S J L , Pochopień , M , Postma , M J , van Loon , J M T & Paulissen , J H J 2023 , ' Cost-effectiveness of finerenone in chronic kidney disease associated with type 2 diabetes in The Netherlands ' , Cardiovascular Diabetology , vol. 22 , no. 1 , 328 . https://doi.org/10.1186/s12933-023-02053-6;
2023
3
Simons, Joost J. M., Vida, Nora, Westra, Tjalke A., Postma, Maarten J.
Veröffentlicht in: Simons , J J M , Vida , N , Westra , T A & Postma , M J 2020 , ' Cost-effectiveness analysis of a gender-neutral human papillomavirus vaccination program in the Netherlands ' , Vaccine , vol. 38 , no. 30 , pp. 4687-4694 . https://doi.org/10.1016/j.vaccine.2020.05.031;
2020
Veröffentlicht in: Simons , J J M , Vida , N , Westra , T A & Postma , M J 2020 , ' Cost-effectiveness analysis of a gender-neutral human papillomavirus vaccination program in the Netherlands ' , Vaccine , vol. 38 , no. 30 , pp. 4687-4694 . https://doi.org/10.1016/j.vaccine.2020.05.031;
2020
4
Mihajlović, Jovan, Dolk, Christiaan, Tolley, Keith, Simoens, Steven, Postma, Maarten J.
Veröffentlicht in: Mihajlović , J , Dolk , C , Tolley , K , Simoens , S & Postma , M J 2015 , ' Reimbursement of Targeted Cancer Therapies Within 3 Different European Health Care Systems ' , Clinical Therapeutics , vol. 37 , no. 2 , pp. 474-480 . https://doi.org/10.1016/j.clinthera.2014.12.005;
2015
Veröffentlicht in: Mihajlović , J , Dolk , C , Tolley , K , Simoens , S & Postma , M J 2015 , ' Reimbursement of Targeted Cancer Therapies Within 3 Different European Health Care Systems ' , Clinical Therapeutics , vol. 37 , no. 2 , pp. 474-480 . https://doi.org/10.1016/j.clinthera.2014.12.005;
2015
5
De Jong, Lisa A., Gout-Zwart, Judith J., Stevanovic, Jelena, Rila, Harrie, Koops, Mike, Huisman, Menno V., Postma, Maarten J.
Veröffentlicht in: De Jong , L A , Gout-Zwart , J J , Stevanovic , J , Rila , H , Koops , M , Huisman , M V & Postma , M J 2018 , ' Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands : Clinical and Economic Effects ' , BMJ Open , vol. 2 , no. 3 , pp. e315-e324 . https://doi.org/10.1055/s-0038-1672185;
2018
Veröffentlicht in: De Jong , L A , Gout-Zwart , J J , Stevanovic , J , Rila , H , Koops , M , Huisman , M V & Postma , M J 2018 , ' Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands : Clinical and Economic Effects ' , BMJ Open , vol. 2 , no. 3 , pp. e315-e324 . https://doi.org/10.1055/s-0038-1672185;
2018
6
Stevanovic, Jelena, Pompen, Marjolein, Le, Hoa H., Rozenbaum, Mark H., Tieleman, Robert G., Postma, Maarten J.
Veröffentlicht in: Stevanovic , J , Pompen , M , Le , H H , Rozenbaum , M H , Tieleman , R G & Postma , M J 2014 , ' Economic evaluation of apixaban for the prevention of stroke in non-valvular atrial fibrillation in the Netherlands ' , PLoS ONE , vol. 9 , no. 8 , e103974 . https://doi.org/10.1371/journal.pone.0103974;
2014
Veröffentlicht in: Stevanovic , J , Pompen , M , Le , H H , Rozenbaum , M H , Tieleman , R G & Postma , M J 2014 , ' Economic evaluation of apixaban for the prevention of stroke in non-valvular atrial fibrillation in the Netherlands ' , PLoS ONE , vol. 9 , no. 8 , e103974 . https://doi.org/10.1371/journal.pone.0103974;
2014